Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May;75(5):2107-11.
doi: 10.1002/mrm.26151. Epub 2016 Feb 18.

Safety and technique of ferumoxytol administration for MRI

Shreyas S Vasanawala  1 , Kim-Lien Nguyen  2 , Michael D Hope  3 , Mellena D Bridges  4 , Thomas A Hope  3 , Scott B Reeder  5 , Mustafa R Bashir  6
Affiliations
Review

Safety and technique of ferumoxytol administration for MRI

Shreyas S Vasanawala et al. Magn Reson Med. 2016 May.

Abstract

Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.

Keywords: contrast agent; ferumoxytol; iron oxide; safety.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Representative applications include detailed cardiovascular imaging (top) and assessment of tumor perfusion through pre-(bottom left) and postcontrast (bottom right) imaging in a patient with a single kidney nearly replaced by metastasis.
See this image and copyright information in PMC

References

    1. Hetzel D, Strauss W, Bernard K, Li Z, Urboniene A, Allen LF. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy. Am J Hematol. 2014;89:646–650. - PMC - PubMed
    1. Vadhan-Raj S, Strauss W, Ford D, Bernard K, Boccia R, Li J, Allen LF. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol. 2014;89:7–12. - PMC - PubMed
    1. Macdougall IC, Strauss WE, McLaughlin J, Li Z, Dellanna F, Hertel J. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. Clin J Am Soc Nephrol. 2014;9:705–712. - PMC - PubMed
    1. Schiller B, Bhat P, Sharma A. Safety and effectiveness of ferumoxytol in hemodialysis patients at 3 dialysis chains in the United States over a 12-month period. Clin Ther. 2014;36:70–83. - PubMed
    1. Auerbach M, Strauss W, Auerbach S, Rineer S, Bahrain H. Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am J Hematol. 2013;88:944–947. - PubMed